Eun Joo Baek
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eun Joo Baek has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Kwang Joong Kim
Department of Dermatology College of Medicine, Hallym University Sacred Heart Hospital Anyang Gyeonggi‐do Korea
4 shared publications - Eun Joo Park
Department of Dermatology, Hallym University Sacred Heart Hospital, Anyang, Korea
3 shared publications - Suk Bae Seo
SeoAh Song Dermatologic Clinic, Seoul 05557, Republic of Korea
2 shared publications Da Yeon Jung
Department of Dermatology, College of Medicine Hallym University Anyang Korea
1 shared publication- Dong Yeol Oh
Department of Dermatology Hallym University Sacred Heart Hospital Anyang Korea
1 shared publication - Eun Hye Hong
Department of Dermatology, Hallym University Sacred Heart Hospital, Anyang, Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
Alitretinoin for the Treatment of Lichen Amyloidosis: A Retrospective, Observational Study and an In Vitro Study
Background: Lichen amyloidosis (LA) is the most common form of localized cutaneous amyloidosis, often accompanied by severe pruritus. Treatment options are limited, and alitretinoin, a systemic retinoid, has shown promise in managing refractory cases. Objective: This study aimed to evaluate the efficacy of alitretinoin in treating LA and its effects on keratinocytes. Methods: We conducted a retrospective analysis of 13 patients diagnosed with LA treated with alitretinoin. In addition, an in vitro study assessed the impact of alitretinoin on keratinocyte inflammation markers. Results: Of the 13 patients, 4 (30.77%) achieved complete clearance of lesions, demonstrating excellent improvement. The remaining 9 (69.23%) showed substantial improvement, with almost clear or mild residual lesions. In vitro, alitretinoin significantly decreased levels of IL‐33, periostin, CCL5, and PTGES. Conclusion: Alitretinoin demonstrated effectiveness in treating LA, with favorable outcomes in both clinical and in vitro settings. These findings support alitretinoin as a viable treatment option for LA.
- 1 January 2025
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
Open AccessAlitretinoin for the Treatment of Lichen Amyloidosis: A Retrospective, Observational Study and an In Vitro Study
Background: Lichen amyloidosis (LA) is the most common form of localized cutaneous amyloidosis, often accompanied by severe pruritus. Treatment options are limited, and alitretinoin, a systemic retinoid, has shown promise in managing refractory cases. Objective: This study aimed to evaluate the efficacy of alitretinoin in treating LA and its effects on keratinocytes. Methods: We conducted a retrospective analysis of 13 patients diagnosed with LA treated with alitretinoin. In addition, an in vitro study assessed the impact of alitretinoin on keratinocyte inflammation markers. Results: Of the 13 patients, 4 (30.77%) achieved complete clearance of lesions, demonstrating excellent improvement. The remaining 9 (69.23%) showed substantial improvement, with almost clear or mild residual lesions. In vitro, alitretinoin significantly decreased levels of IL‐33, periostin, CCL5, and PTGES. Conclusion: Alitretinoin demonstrated effectiveness in treating LA, with favorable outcomes in both clinical and in vitro settings. These findings support alitretinoin as a viable treatment option for LA.
- 11 January 2024
- Published by Wiley in Contact Dermatitis
- Vol. 90 (4) , 385-393
Immunohistochemical differentiation of keratins and involucrin between palmar psoriasis, chronic hand eczema and hyperkeratotic hand eczema
Background: Common hyperkeratotic palmar skin lesions include chronic hand eczema (CHE), hyperkeratotic hand eczema (HHE), palmar psoriasis (PP). However, clinically differentiating these disorders is often challenging.Objectives: To compare the expressions of keratin (K) 5, K9, K14 and involucrin in palmar hyperkeratotic lesions (HHE, CHE and PP).Materials and Methods: Immunohistochemical staining was performed on skin biopsy specimens obtained from the palms of patients clinically diagnosed with CHE, HHE and PP (n = 21, 24 and 18, respectively).Results: K5 and K14 expression levels were higher in the spinous and granular layers of PP and HHE compared to CHE. Involucrin was expressed in the basal layer of PP and HHE but not in CHE. K9 expression was decreased in PP and HHE compared to CHE.Conclusion: Keratin and involucrin expression in the epidermis are markers of keratinocyte differentiation. Expression levels of keratin and involucrin were similar between the HHE and PP groups, suggesting that HHE shares pathogenesis with PP rather than CHE.
- 11 January 2024
- Published by Wiley in Contact Dermatitis
- Vol. 90 (4) , 385-393
Immunohistochemical differentiation of keratins and involucrin between palmar psoriasis, chronic hand eczema and hyperkeratotic hand eczema
Background: Common hyperkeratotic palmar skin lesions include chronic hand eczema (CHE), hyperkeratotic hand eczema (HHE), palmar psoriasis (PP). However, clinically differentiating these disorders is often challenging.Objectives: To compare the expressions of keratin (K) 5, K9, K14 and involucrin in palmar hyperkeratotic lesions (HHE, CHE and PP).Materials and Methods: Immunohistochemical staining was performed on skin biopsy specimens obtained from the palms of patients clinically diagnosed with CHE, HHE and PP (n = 21, 24 and 18, respectively).Results: K5 and K14 expression levels were higher in the spinous and granular layers of PP and HHE compared to CHE. Involucrin was expressed in the basal layer of PP and HHE but not in CHE. K9 expression was decreased in PP and HHE compared to CHE.Conclusion: Keratin and involucrin expression in the epidermis are markers of keratinocyte differentiation. Expression levels of keratin and involucrin were similar between the HHE and PP groups, suggesting that HHE shares pathogenesis with PP rather than CHE.
- Open Access
- 1 January 2023
- Published by Wiley in Dermatologic Therapy
- Vol. 2023 (1)
Treatment for Aging Skin with Multifrequency Radiofrequency
Background. Radiofrequency treatment improves skin aging‐related concerns by promoting collagen production. However, studies of the efficacy of multifrequency radiofrequency (MFRF) are lacking. Objectives. This study aimed to analyze the efficacy of MFRF for patients with aging skin. Methods. Three MFRF treatment sessions were performed for patients with concerns about skin aging. During these sessions, MFRF was applied to the face (but not the forehead). Pores, wrinkles, subjective satisfaction, and side effects were evaluated at the first visit and 4 weeks after the last treatment. Additionally, histological and immunohistochemical evaluations of collagen, elastic fibers, and STRO‐1 were performed. Results. Wrinkles and the subjective satisfaction of patients were significantly improved (p = 0.034 and p = 0.001, respectively). However, there was no significant effect on the number of pores (p = 0.429). All side effects that occurred after treatment were tolerable and transient. Histological findings revealed thickening of collagen bundles and elastic fibers. Additionally, increases in collagen I, collagen III, and STRO‐1 levels were observed using immunohistochemistry. Conclusions. MFRF treatment uses less energy than the existing radiofrequency equipment and can be an effective clinicopathologic modality for facial rejuvenation.
- 1 January 2023
- Published by Wiley in Dermatologic Therapy
- Vol. 2023 (1)
Open AccessTreatment for Aging Skin with Multifrequency Radiofrequency
Background. Radiofrequency treatment improves skin aging‐related concerns by promoting collagen production. However, studies of the efficacy of multifrequency radiofrequency (MFRF) are lacking. Objectives. This study aimed to analyze the efficacy of MFRF for patients with aging skin. Methods. Three MFRF treatment sessions were performed for patients with concerns about skin aging. During these sessions, MFRF was applied to the face (but not the forehead). Pores, wrinkles, subjective satisfaction, and side effects were evaluated at the first visit and 4 weeks after the last treatment. Additionally, histological and immunohistochemical evaluations of collagen, elastic fibers, and STRO‐1 were performed. Results. Wrinkles and the subjective satisfaction of patients were significantly improved (p = 0.034 and p = 0.001, respectively). However, there was no significant effect on the number of pores (p = 0.429). All side effects that occurred after treatment were tolerable and transient. Histological findings revealed thickening of collagen bundles and elastic fibers. Additionally, increases in collagen I, collagen III, and STRO‐1 levels were observed using immunohistochemistry. Conclusions. MFRF treatment uses less energy than the existing radiofrequency equipment and can be an effective clinicopathologic modality for facial rejuvenation.
- 12 March 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (5) , e15419
Comparative study of treatment methods for benign lichenoid keratosis of the face
Benign lichenoid keratosis is one of the most common skin lesions that develop on the faces of middle-aged women. This study aimed to find an effective treatment method for benign lichenoid keratosis. A total of 49 patients, who had a positive diagnosis during 2010-2018, were enrolled in the study. An Investigator's Global Assessment of the lesion was done using the 5-point visual analog scale to evaluate treatment efficacy. After excluding subjects who did not have a follow-up photograph, 38 subjects were given an Investigator's Global Assessment score. Combination therapy using laser and a topical agent was useful in the management of benign lichenoid keratosis on the face. Ablative laser was effective for immediate improvement of the lesion, whereas non-ablative laser was also useful and showed several benefits over ablative laser. Optimal treatment should be decided after considering the patient's preference, compliance with treatment regimen, and skin type.
- 12 March 2022
- Published by Wiley in Dermatologic Therapy
- Vol. 35 (5) , e15419
Comparative study of treatment methods for benign lichenoid keratosis of the face
Benign lichenoid keratosis is one of the most common skin lesions that develop on the faces of middle-aged women. This study aimed to find an effective treatment method for benign lichenoid keratosis. A total of 49 patients, who had a positive diagnosis during 2010-2018, were enrolled in the study. An Investigator's Global Assessment of the lesion was done using the 5-point visual analog scale to evaluate treatment efficacy. After excluding subjects who did not have a follow-up photograph, 38 subjects were given an Investigator's Global Assessment score. Combination therapy using laser and a topical agent was useful in the management of benign lichenoid keratosis on the face. Ablative laser was effective for immediate improvement of the lesion, whereas non-ablative laser was also useful and showed several benefits over ablative laser. Optimal treatment should be decided after considering the patient's preference, compliance with treatment regimen, and skin type.
- 22 August 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (5) , 1973-1978
The role of sonication in preparing injectable poly‐l‐lactic acid
Background: Injectable poly‐l‐lactic acid (PLLA) carries the risk of nodule or microlump formation. Various methods including sonication have been tried to minimize these adverse effects of PLLA.Aims: This study investigated the change in size, distribution, and properties of PLLA particles after sonication, and the duration of sonication needed to reach the ideal particle size.Methods and Materials: Two indicators, the average size of PLLA particles and diameter at 90%, were measured at each timepoint: at 0, 10, 60, 120, and 240 minutes of sonication. The characteristics and particle shape were assessed at 0 and 240 minutes.Results: The average particle size and the diameter at 90% decreased drastically until 10 minutes of sonication and then increased slightly at 60 minutes. After 60 minutes, the average size and the diameter at 90% gradually decreased over time and reached 42.2 μm and 75.7 μm, respectively, at 120 minutes. After 240 minutes of sonication, the average particle size was 35.9 μm, much smaller than the smallest proper size required (40 μm). Standard deviation decreased gradually over time, which means that a more even distribution was obtained. Crystalline remnants were significantly less left with 120 minutes sonication compared to those with 120 minutes hydration only. PLLA particles were more cracked at the center, and microcrystals were more loosely distributed at the periphery after 120 minutes sonication.Conclusion: Sonication help reduce the average size of PLLA particles and achieve more even distribution. Therefore, we believe sonication may attribute to the safer use of PLLA.
- 22 August 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 21 (5) , 1973-1978
The role of sonication in preparing injectable poly‐l‐lactic acid
Background: Injectable poly‐l‐lactic acid (PLLA) carries the risk of nodule or microlump formation. Various methods including sonication have been tried to minimize these adverse effects of PLLA.Aims: This study investigated the change in size, distribution, and properties of PLLA particles after sonication, and the duration of sonication needed to reach the ideal particle size.Methods and Materials: Two indicators, the average size of PLLA particles and diameter at 90%, were measured at each timepoint: at 0, 10, 60, 120, and 240 minutes of sonication. The characteristics and particle shape were assessed at 0 and 240 minutes.Results: The average particle size and the diameter at 90% decreased drastically until 10 minutes of sonication and then increased slightly at 60 minutes. After 60 minutes, the average size and the diameter at 90% gradually decreased over time and reached 42.2 μm and 75.7 μm, respectively, at 120 minutes. After 240 minutes of sonication, the average particle size was 35.9 μm, much smaller than the smallest proper size required (40 μm). Standard deviation decreased gradually over time, which means that a more even distribution was obtained. Crystalline remnants were significantly less left with 120 minutes sonication compared to those with 120 minutes hydration only. PLLA particles were more cracked at the center, and microcrystals were more loosely distributed at the periphery after 120 minutes sonication.Conclusion: Sonication help reduce the average size of PLLA particles and achieve more even distribution. Therefore, we believe sonication may attribute to the safer use of PLLA.